Masterclass in Kiel — Focus on Peyronie’s Disease and Functional Andrology

Register Now

On 21 November 2025, the Institute of Anatomy, Christian-Albrechts University, Kiel (Germany), will host an afternoon masterclass dedicated to Peyronie’s disease and regenerative approaches to erectile dysfunction.

Part of the 2025 Sexual Medicine programme by BioBridge, this intensive session combines theoretical lectures with hands-on practice on fresh cadavers.

Practical details

Date & time: 21 November 2025, afternoon session (~4 hours)

Venue: Institute of Anatomy, Christian-Albrechts University, Otto-Hahn-Platz 8, 24118 Kiel, Germany

Capacity: 15 participants (strictly limited to ensure interactive learning)

Fee: €250 per participant

Registration: Request form available on the BioBridge website

2

Content & format
This focused half-day course covers the essentials of uro-andrological practice with particular emphasis on Peyronie’s disease:

  • Biological basis of regenerative injectable therapies (PRP, combination approaches)

  • Injection techniques tailored to Peyronie’s disease management

  • Indications, limitations, and integration of surgical approaches

  • Practical cadaveric sessions to visualise anatomical structures and refine injection techniques

  • Case discussions and clinical “watch-outs”

Why attend?
The Kiel Masterclass is a rare opportunity to receive highly targeted, practical training on Peyronie’s disease, with direct cadaveric practice and close interaction with international experts.

Conclusion
Spaces are strictly limited to 15 participants — early application is essential. Join this exclusive training to refine your skills in regenerative and surgical management of Peyronie’s disease.

The masterclass will be conducted by a distinguished international faculty:

Prof. Daniar Osmonov

Urologist & Andrologis (Kiel, Germany)

Dr. Sam Ward

Uro-Andrology, MD (Brussels, Belgium)

Dr. Sébastien Beley

Uro-Andrology, MD (France)

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.